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Abstract. 
 
We have isolated a murine cDNA encoding a
9-kD protein, Chisel (Csl), in a screen for transcrip-
tional targets of the cardiac homeodomain factor Nkx2-
 
5. 
 
Csl
 
 transcripts were detected in atria and ventricles of
the heart and in all skeletal muscles and smooth muscles
of the stomach and pulmonary veins. Csl protein was
distributed throughout the cytoplasm in fetal muscles,
although costameric and M-line localization to the mus-
cle cytoskeleton became obvious after further matura-
tion. Targeted disruption of 
 
Csl
 
 showed no overt muscle
 
phenotype. However, ectopic expression in C2C12 myo-
blasts induced formation of lamellipodia in which Csl
 
protein became tethered to membrane rufﬂes. Migration
of these cells was retarded in a monolayer wound repair
assay. Csl-expressing myoblasts differentiated and fused
normally, although in the presence of insulin-like growth
factor (IGF)-1 they showed dramatically enhanced fu-
sion, leading to formation of large dysmorphogenic “myo-
sacs.” The activities of transcription factors nuclear factor
 
of activated T cells (NFAT) and myocyte enhancer–
binding factor (MEF)2, were also enhanced in an IGF-1
signaling–dependent manner. The dynamic cytoskeletal
localization of Csl and its dominant effects on cell shape
and behavior and transcription factor activity suggest
that Csl plays a role in the regulatory network through
which muscle cells coordinate their structural and func-
tional states during growth, adaptation, and repair.
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Introduction
 
The mammalian heart is an organ of considerable struc-
tural and regulatory complexity. Emphasis is now being
placed on unraveling the genetic circuitry underlying car-
diac patterning and morphogenesis and how this relates to
congenital disease (Fishman and Chien, 1997). A key gene
in the myocardial developmental regulatory hierarchy in
 
vertebrates is 
 
Nkx2-5
 
, a homologue of the 
 
Drosophila
 
 ho-
meobox gene, 
 
tinman,
 
 essential for specification of the
heart and visceral muscle lineages in the fly (Harvey, 1996).
 
Nkx2-5
 
 can promote cardiogenesis in vitro (Skerjanc et al.,
1998) and to a limited extent in vivo (Cleaver et al., 1996)
and can rescue some of the functions of 
 
tinman
 
 when ex-
pressed as a transgene in 
 
tinman
 
-mutant 
 
Drosophila
 
 em-
bryos (Park et al., 1998; Ranganayakulu et al., 1998). In
frogs, dominant negative inhibition of Nkx2-5 leads to
complete obliteration of heart formation, suggesting an es-
sential role in specification of the cardiac lineages in this
vertebrate (Fu et al., 1998; Grow and Krieg, 1998). Ho-
mozygous mutations in murine 
 
Nkx2-5
 
 lead to arrest of
cardiac morphogenesis at the linear heart tube stage (Ly-
ons et al., 1995; Tanaka et al., 1999; Biben et al., 2000),
whereas heterozygous mutations in both the human and
 
mouse genes confer atrial septal defects and conduction ab-
normalities (Schott et al., 1998; Biben et al., 2000). Nkx2-5
is thought to act, in part, via its association with the tran-
scription factors GATA4 (Durocher et al., 1997) and se-
rum response factor (Chen and Schwartz, 1996), and in
vivo and/or in vitro studies have identified 
 
atrial natriuretic
 
factor
 
, 
 
A1 adenosine receptor
 
,
 
 calreticulin
 
, and 
 
 
 
-cardiac ac-
tin
 
 as direct target genes (Chen and Schwartz, 1996; Duro-
cher et al., 1996; Biben et al., 1997; Rivkees et al., 1999;
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Guo et al., 2000)
 
.
 
 However, in knockout mice genes encod-
ing the regionally expressed transcription factors Hand1/
eHand, Irx4, Msx-2, and N-myc and the actin cross-linking
protein SM-22
 
  
 
are also dysregulated (Biben and Harvey,
1997; Biben et al., 1997; Tanaka et al., 1999; Bruneau et al.,
2000), suggesting a role for Nkx2-5 in the development of
patterning information and heart tube morphogenesis.
In this paper, we describe the gene 
 
Chisel
 
 (
 
Csl
 
),
 
1
 
 which
was cloned during a differential screen for genes downreg-
ulated in homozygous 
 
Nkx2-5
 
 mutant hearts. 
 
Csl
 
 encodes
a protein of 9 kD expressed in the heart, all skeletal mus-
cles, and smooth muscles of the stomach and pulmonary
veins. In the heart, 
 
Csl
 
 transcripts were expressed only in
the specialized working myocardium of the atrial and ven-
tricular chambers. Although 
 
Csl
 
 knockout mice showed no
obvious phenotype, over-expression in the C2C12 myo-
genic cell line led to effects on cytoskeletal dynamics in
myoblasts and cell signaling–dependent enhancement of
cell fusion in myocytes. The activities of nuclear factor of
activated T cells (NFAT) and myocyte enhancer–binding
factor (MEF)2 transcription factors were also enhanced in
a cell signaling–dependent manner. These data suggest
that Csl acts in the signaling network through which the
structural, functional, and regulatory states of muscle cells
are coordinated.
 
Materials and Methods
 
DNA and RNA Analysis
 
RNase protections were performed according to Ambion methods. 
 
Csl
 
probe corresponded to residues 257–392 of the cDNA (see Fig. 1). 
 
Cyclo-
philin
 
 probe was synthesized from a template obtained from Ambion. In
situ hybridization was performed as described (Biben and Harvey, 1997).
 
Csl
 
 probe corresponded to bases 9–787 of the cDNA (see Fig. 1). Oligonu-
cleotides used for genotyping knockout mice were: common forward
primer, 5
 
 
 
-ccttgaatctgaaggctgcc-3
 
 
 
; wild-type reverse, 5
 
 
 
-cgttcaggacccacat-
gaag-3
 
 
 
; 
 
fAP
 
 allele reverse, 5
 
 
 
-ccatcagaagctgactctag-3
 
 
 
; and 
 
AP
 
 
 
 allele re-
verse, 5
 
 
 
-tctgtgcaggctgcagcttc-3
 
 
 
.
 
Production of an Anti-Csl Antibody
 
Glutathione 
 
S
 
-transferase (GST)–Csl fusion protein was produced from
pGEX-2T (Amersham Pharmacia Biotech). Fusion protein was cleaved
from a glutathione–Sepharose 4B column (Amersham Pharmacia Bio-
tech) using 5 U/ml thrombin (Amersham Pharmacia Biotech) at 4
 
 
 
C over-
night. Two rabbits were immunized with 600 
 
 
 
g of recombinant Csl in
Freund’s Adjuvant (1:1) and boosted with 600 
 
 
 
g monthly (Institute of
Medical and Veterinary Science, Adelaide, Australia). IgG fraction was
purified on protein G–Sepharose (Pharmacia Amersham Biotech). Since
IgG from both rabbits contained antibodies that cross-reacted with
desmin, Csl antibody was routinely immunoabsorbed against desmin fu-
sion protein (amino acids 412–470).
 
Western Blot Analysis
 
PVDF membranes (Millipore) were blocked with 0.05% Tween 20, 2%
bovine serum albumin, PBS. Csl antibody (1:1,500) was followed by anti–
rabbit IgG conjugated to HRP (1:1,000; Silenus). mAbs anti-Hsp 70
(1:1,000; Sigma-Aldrich) and anti-Akt (1:2,000; New England Biolabs,
Inc.) were used with anti–mouse IgG–HRP (Silenus). Bands were de-
tected by chemiluminescence (Amersham Pharmacia Biotech).
 
Cell Culture
 
Csl
 
 cDNA was cloned into pEF FLAG A (a gift from David Huang,
Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria,
Australia), pEFBosMyc (a gift from N. Nicola, Walter and Eliza Hall Insti-
tute of Medical Research), pEGFP-C1 (CLONTECH Laboratories, Inc.),
and a vector carrying a myosin light chain (MLC)1 promoter/enhancer
(Musaro and Rosenthal, 1999). Activated calcineurin A was cloned into
pPGKpuropAv18 (a gift from David Huang). Transfections were per-
formed with lipofectamine (GIBCO BRL) according to instructions. pEF
FLAG A was used at 10:1 for puromycin selection where necessary. Two
sublines of C2C12 cells were used. FLAG-Csl lines were made from stocks
held at the Walter and Eliza Hall Institute of Medical Research and grown
as described (Semsarian et al., 1999). Myc-Csl lines were made in cells
from the laboratory of H. Blau (Stanford University, Palo Alto, CA) and
grown in low glucose DME, 20% FBS, and 0.5% chick embryo extract. In
transfections, reporter plasmids were cotransfected with an SV40-LacZ
expression plasmid (9:1) for normalization. Luciferase activity was deter-
mined using Promega reagents. Flow cytometry was performed on a Bec-
ton Dickinson FACSCalibur™.
 
Immunofluorescence
 
C2C12 cells on coverslips were fixed in ice-cold acetone for 15 min or in 4%
paraformaldehyde (PFA)/PBS for a minimum of 15 min, followed by 0.5%
Triton X-100/PBS for 15 min as appropriate for each antigen. For cryosec-
tions, tissue was embedded in OCT compound (Tissue-Tek) and immersed
in isopentane cooled almost to the point of solidity using liquid nitrogen.
Sections were fixed in ice-cold acetone or 4% PFA/PBS for 15 min. Anti-
bodies were as follows: anti–
 
 
 
-actinin mouse mAb (Sigma-Aldrich) (EA-
53, 1:100; acetone/PFA fixation); antimyosin heavy chain IIb mouse IgM
mAb (supplied by Edna Hardeman, Children’s Medical Research Institute,
Wentworthville, New South Wales, Australia) (neat; acetone fixation);
anti-Csl rabbit polyclonal (1:200; PFA); antimyosin heavy chain mAb
(MF20; Developmental Studies Hybridoma Bank) (1:20; acetone); antitalin
mAb (Sigma-Aldrich) (1:20; PFA); antimyosin heavy chain I/slow mAb
(supplied by Edna Hardeman) (neat; PFA); anti-myc epitope mAb (9E10;
Developmental Studies Hybridoma Bank) (1:10; PFA). Confocal images
were obtained using a Leica TCS NT system. Photomicrographs were pre-
pared using a Spot-II digital system (Diagnostics Instruments).
 
Calcineurin Assays
 
Calcineurin activity was assayed as described (Semsarian et al., 1999) us-
ing okadaic acid at 1 
 
 
 
M and calmodulin at 250 nM. Calcineurin activity
was calculated as the difference between total phosphatase activity on tar-
get peptide (Auspep) with and without 1 
 
 
 
M cyclosporine A (CsA) added
to cells 20 min before preparation of extracts or with and without addition
of calcineurin autoinhibitory peptide (500 
 
 
 
M) (Calbiochem) to extracts.
 
Wounding Assays
 
Parallel 150-
 
 
 
m wounds were made in confluent monolayers using a
flame-polished glass needle on a micromanipulator. After 6 h in culture,
cells were fixed (4% PFA/PBS) and stained (1% eosin). Wound areas
were measured before and after culture using Leica Q500MC software.
 
Results
 
Cloning of Mouse Csl
 
A cDNA fragment encoding a novel protein termed Csl
(cardiac and skeletal muscle protein) was cloned during
a differential screen for transcriptional targets of the
cardiac-expressed homeodomain factor Nkx2-5 (Harvey,
1996). The basis of the screen was a targeted mouse line
carrying a null allele of 
 
Nkx2-5
 
 (
 
Nkx2-5
 
HDneo
 
) (Lyons et
al., 1995; Biben et al., 2000). Hearts from wild-type and
homozygous mutant embryos were dissected at embryonic
day (E)8.5, and total RNA was extracted and converted to
cDNA using the CapFinder PCR cDNA synthesis kit
(CLONTECH Laboratories, Inc.). cDNAs were then am-
 
1
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plified using PCR and used in a suppression subtractive
hybridization procedure (PCR-Select; CLONTECH Lab-
oratories, Inc.). Selective PCR amplification of differen-
tially expressed products yielded several fragments, one of
which encoded Csl. Hybridization of a 
 
Csl
 
 probe to South-
ern filters carrying an equal mass of mutant and wild-type
cDNAs demonstrated that 
 
Csl
 
 was downregulated more
than 20 times in the mutant context (data not shown).
The DNA sequence of 
 
Csl
 
 showed identity or near iden-
tity to numerous mouse, human, rat, and pig ESTs. Using
mouse ESTs, primers were designed, and a near full-
length cDNA was amplified by reverse transcriptase–PCR
from heart RNA, and after cloning multiple isolates were
sequenced (Fig. 1 A). BLAST searching revealed that the
complete sequence of the human gene spread over five ex-
ons was present on two overlapping and fully sequenced
cosmid clones derived from the X chromosome (sequence
data available from GenBank/EMBL/DDBJ under acces-
sion nos. U73508 and U73509; Grieff et al., 1997). Fur-
thermore, the complete rat coding sequence could be as-
sembled from overlapping ESTs. We also isolated and
sequenced a 
 
Xenopus
 
 
 
laevis
 
 cDNA (Fig. 1 B) and a partial
cDNA from zebrafish (Yelon, D., and D. Stainier, unpub-
lished data). However, searches of the 
 
Drosophila
 
 
 
melano-
gaster
 
 and 
 
Caenorhabditis elegans
 
 genomes did not detect
 
Csl
 
-related genes. During the course of this study, 
 
Csl
 
 was
cloned independently from humans as an X-linked car-
diac-expressed gene (Patzak et al., 1999). We determined
the chromosomal position of mouse 
 
Csl
 
 by interspecific
backcross analysis using a panel of ([C57BL/6J 
 
 
 
 
 
Mus
spretus
 
]F1 
 
 
 
 C57BL/6J) mice (Copeland and Jenkins,
1991). As in humans (Grieff et al., 1997; Patzak et al.,
1999), 
 
Csl
 
 mapped to the X chromosome and was linked to
genes 
 
Btk
 
 and 
 
Figf
 
 (data not shown).
Csl proteins were similar in length (85–91 amino acids)
with the frog protein being slightly longer than its mam-
malian counterparts due to the presence of a pentapeptide
insertion (Fig. 1 B). Alignments demonstrated strong con-
servation during vertebrate evolution; mouse Csl is 74%
identical to frog Csl and 86 and 92% identical to the hu-
man and rat Csl, respectively. No homology was found be-
tween Csl and other proteins in public databases.
 
Csl mRNA Expression in the Embryo and Adult
 
Most 
 
Csl
 
 ESTs were derived from heart and skeletal mus-
cle. RNase protection analysis of mRNA samples ex-
tracted from a variety of adult mouse tissues showed a
strong signal in heart, skeletal muscle, and tongue (Fig. 2
A) with a weaker signal in lung, testes, and large intestine.
Northern blot analysis of RNA from the C2C12 myogenic
cell line revealed a predominant mRNA species of 1.1–1.2
kb (see Fig. 9 A).
Using in situ hybridization, 
 
Csl
 
 transcripts were first de-
tected at E8.25 in myocytes located at the ventral surface
of the heart progenitor region undergoing active fusion
(Fig. 2, B and C). During the early stages of heart looping
(E8–E8.5), 
 
Csl
 
 transcripts were restricted to the myocar-
dial layer at the outer curvature of the presumptive left
and right ventricles (Fig. 2, D and E). By E9.5–10.5, tran-
scripts were also evident in the developing sinoatrial re-
gion in a left–right asymmetric pattern (Fig. 2, F–I). On
the right side, the developing right atrium and right horn
of the sinus venosus were strongly positive, whereas on the
left a disc-shaped pattern was evident in the dorsolateral
region of the common atrium, suggestive of the future po-
sition of the left atrial appendage (Fig. 2, G and I). How-
ever, the left sinus horn was negative for 
 
Csl
 
 expression.
 
Csl
 
 expression was undetectable in most of the atrioven-
tricular canal, the inner curvature, and in myocardium as-
sociated with the forming atrial septum (Fig. 2, G and I).
The outflow tract was also negative, except for a unique
rib of expression along its outer curvature (Fig. 2 F). Dur-
ing fetal development, 
 
Csl
 
 expression continued in the
outer curvature of the ventricles and in the atrial append-
ages, as reported in a separate study in which 
 
Csl
 
 was used
as an anonymous probe (Christoffels et al., 2000). As ex-
pected, 
 
Csl
 
 expression in homozygous 
 
Nkx2-5
 
 mutant em-
bryos was strongly downregulated (Fig. 2 J).
 
Csl
 
 was also expressed in developing skeletal muscles
from E11.5. At E13.5, transcripts were evident in the myo-
tomal compartment of somites and in developing limb,
head, and neck muscles in a pattern resembling that of the
myogenic regulatory factor gene 
 
myogenin
 
 (Fig. 2 K).
 
Creation of Csl Knockout Mice
 
To assess the function of 
 
Csl
 
 in muscle development, we
generated mutant mice by gene targeting. We designed a
Figure 1. (A) DNA sequence of mouse Csl cDNA with pre-
dicted protein. (B) Alignment of human, mouse, rat, and Xeno-
pus Csl proteins. Shaded amino acids indicate nonidentity. (Csl
cDNA sequence data available from GenBank/EMBL/DDBJ un-
der accession nos. AY026524 [mouse] and AF343894 [Xenopus]). 
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conditional targeted allele in which a neomycin resistance
cassette was inserted in reverse orientation into the second
intron of the 
 
Csl
 
 gene, and Lox
 
 
 
P
 
 
 
sites were inserted within
the untranslated region of the first coding exon (exon 2)
upstream of the predicted initiation codon and down-
stream of the neomycin cassette (Fig. 3 A). A human pla-
cental alkaline phosphatase (hPAP) cDNA was also in-
serted just downstream of the neomycin cassette such that
it replaces exon 2 coding sequences after Cre-mediated
deletion. The correctly targeted conditional 
 
Csl
 
 allele
(
 
Csl
 
fAP
 
) was detected in 1 in 22 (7/153) neomycin-resistant
W9.5 embryonic stem cell colonies. Conditional 
 
Csl
 
 lines
were established from two independently targeted embry-
onic stem cell clones, and lines carrying the Cre-deleted al-
lele (
 
Csl
 
AP
 
 
 
) were successfully established after crossing
founder chimeras with transgenic mice expressing Cre re-
combinase in the germline (TgN[CMV-Cre]1Cgn) (Schwenk
 
et al., 1995). Founders were outcrossed onto C57BL/6
mice and progeny were genotyped using PCR (Fig. 3 B).
The official designators (Institute for Laboratory Animal
Research; http://www4.nas.edu/cls/ilarhome.nsf) for the con-
ditional and Cre-deleted 
 
Csl
 
 mutant strains are Csltm1Rph
and Csltm1.1Rph, respectively.
Western blot analysis of muscle and heart extracts from
adult male CslAP  mutant mice using an anti-Csl polyclonal
antibody revealed no detectable Csl protein (Fig. 4 B), dem-
onstrating that the knockout allele is null. Nevertheless,
knockout mice displayed no obvious developmental or
structural deficit in heart or skeletal muscle (see Discussion).
Detection of Csl Protein in Muscle and C2C12 Cells
Western blotting revealed a prominent 9-kD band in skel-
etal muscle and heart (Fig. 4 A), consistent with the pre-
Figure 2. Csl mRNA expres-
sion. (A) RNase protection
analysis of Csl and control cy-
clophilin (Cyclo) mRNAs in
adult mouse tissues. (B–K)
Whole-mount in situ hybrid-
ization using Csl probe on
mouse embryos. (B) Ventral
view of E8.25 embryo. (C)
Section of the embryo shown
in B. Arrows indicate expres-
sion on the ventral surface of
the fusing heart tube. (D)
Ventral view of E8.5 em-
bryo. (E) Section of embryo
depicted in D showing Csl ex-
pression at the outer curva-
ture of the ventricles. (F–H)
E10.5 embryo viewed from
the ventral and left and right
sides, respectively. Arrow in
F indicates rib of expression
in outflow tract. Arrow in G
indicates expression in pre-
sumptive left atrial append-
age. (I) Section of E10.5
heart. Note that expression is
restricted to the outer curva-
ture of the ventricles and
atrial appendages. (J) E9.5
Nkx2-5 /   embryos ( / )
compared with wild-type sib-
ling ( / ). (K) E13.5 em-
bryos comparing expression
of  Csl and myogenin. as,
atrial septum; at, atrium; avc,
atrioventricular canal; lv, left
ventricle; oft, outflow tract;
rs, right sinus horn; rv, right
ventricle; tb, trabeculae.Palmer et al. Expression and Role of Muscle-specific Protein Csl 989
dicted size and distribution of Csl protein. This band was
eliminated by prior incubation of antibody with excess re-
combinant Csl protein (Fig. 4 A). Further analysis showed
that the level of Csl protein was higher in muscles of neo-
natal and postnatal mice (P1–P8) compared with corre-
sponding adult tissues (Fig. 4 B).
Analysis of the mouse C2C12 myogenic cell line (Blau
et al., 1983) using immunofluorescence showed that Csl
was expressed in differentiating myocytes and myotubes
(Fig. 4, D–G), paralleling Csl mRNA expression (see Fig.
9 A). Fluorescence was eliminated by prior incubation of
antibody with excess recombinant Csl protein (Fig. 4 G).
Csl was coexpressed with myofilament proteins in both
round and bipolar mononuclear myocytes (Fig. 4, D and
E; data not shown), indicating activation at the onset of
myogenic differentiation and before fusion. Both native
Csl (Fig. 4, D–F) and transfected myc epitope–tagged Csl
detected with an anti-myc antibody (data not shown) lo-
calized predominantly to the cytoplasm in C2C12 myo-
cytes and myotubes.
Detection of Csl Protein in Adult Tissue Sections
Using immunofluorescence, Csl was robustly expressed in
muscles of the heart in all chambers and in skeletal mus-
cles (Fig. 5 A). Analysis of sections of Csl knockout ani-
mals revealed only background signal, confirming the
specificity of the Csl antibody (Fig. 5 B). Furthermore,
staining for hPAP activity in Csl knockout mice recapitu-
Figure 3. (A) Csl-targeting construct relative to wild-type and
targeted alleles. Large arrowheads indicate direction of LoxP
sites. Black shading within exon 2 indicates Csl-coding region.
Arrows indicate PCR genotyping primers. hPAP, hPAP gene;
pgk-Neo, neomycin resistance gene cassette. (B) Example of
multiplex PCR genotyping of targeted (582 bp), wild-type (517
bp), and Cre-deleted (321 bp) alleles. M, MluI; P, PvuII; X, XbaI.
Figure 4. Csl protein expression. (A) Western blot analysis of
Csl expression in adult tissues. An equal mass of protein was
loaded in each lane. “Blocked” indicates lanes in which Csl anti-
body was preabsorbed with excess recombinant Csl protein. (B)
Western blot analysis of Csl expression in postnatal day (P)1, P8,
and P21, and/or adult tissues from wild-type and male CslAP 
knockout mice using Akt levels as loading control. (C) Compari-
son of levels of Csl expression in heart and different skeletal mus-
cles using Hsp 70 levels as control. Note the additional Hsp 70
isoform enriched in soleus. (D–F) Immunofluorescence analysis
of Csl expression in C2C12 cells after 1, 2, and 4 d, respectively,
in differentiation medium. (G) Immunofluorescence on 4-d cul-
ture after blocking as in A. bm, bipolar mononuclear myocytes;
Diaphm, diaphragm; Gastroc, gastrocnemius; rm, rounded
mononuclear myocytes. Bar, 100  m.The Journal of Cell Biology, Volume 153, 2001 990
lated the immunofluorescence patterns (Fig. 5 C). Muscles
of the fetal and neonatal stomach were also positive (Fig. 5
D), whereas those of the intestines, bladder, and vascula-
ture were negative. Smooth muscles surrounding pulmo-
nary veins, which are cardiac in character (Millino et al.,
2000), also expressed Csl (data not shown), presumably
accounting for the RNase protection signal in lungs (Fig. 2
A). Stomach expression was transient, since RNase pro-
tection analysis (Fig. 2 A) and immunofluorescence (data
not shown) failed to detect Csl transcript or protein in
adults. Csl mRNA was also expressed in testes (Fig. 2 A),
and in knockout mice the germ cell component was hPAP
positive. However, no Csl protein could be detected in
these cells (data not shown).
In adult skeletal muscles, the level of Csl protein varied
considerably between muscles with different metabolic
and functional characteristics. Western blotting showed
that Csl levels were highest in slow oxidative muscles, such
as the soleus, and lowest in fast glycolytic muscles, such as
the gastrocnemius (Fig. 4 C), with intermediate levels in
tongue and diaphragm. This pattern was also evident using
immunofluorescence (Fig. 5, E and H) and in Csl knock-
out mice by hPAP staining (Fig. 5 G). Double immunoflu-
orescence with antibodies against fiber type–specific myo-
sin heavy chains revealed that the level of Csl protein was
in fact graded within individual muscle fibers, with highest
levels in slow type I, intermediate levels in fast type IIa,
and lowest levels in fast type IIb fibers (Fig. 5, E, F, H, and
I; data not shown).
Intracellular Distribution of Csl Protein
In cardiac and skeletal muscles of the fetus, Csl protein
was localized relatively evenly throughout the cell, even in
the presence of clearly organized sarcomeres, revealed by
double immunofluorescence with  -actinin antibody (Fig.
6, A and B). However, a striated pattern of Csl immunolo-
calization became evident from late fetal to neonatal
stages and was the predominant pattern in the adult (Fig.
6, D and J). Confocal microscopic analysis of stretched
slow adult skeletal muscles (soleus) revealed that Csl was
expressed predominantly in repetitive double stripes (Fig.
6, D and G). Doublets localized to the level of the I-band,
Figure 5. Tissue distribution of Csl
protein. Sections from newborn (A–D)
and adult (E–I) mice were analyzed for
Csl and/or myosin heavy chains using
immunofluorescence (A, B, D–F, H,
and I) or for Csl by staining for hPAP
(C and G). (A) Section showing ex-
pression in heart and adjacent skeletal
muscles. (B) Section from a CslAP 
mouse. (C) Section from CslAP  mouse
stained for hPAP. Arrowheads show
nonspecific staining. (D) Section show-
ing Csl expression in smooth muscle of
the stomach. (E and F) Near adjacent
sections showing muscle expression of
Csl (E) and fast myosin heavy chain
IIb (F). (G) Fiber-type pattern of Csl
expression in CslAP  mouse revealed
by hPAP staining. (H and I) Double
immunofluorescence showing muscle
fiber–type pattern of Csl (H) and slow
myosin heavy chain I (I). Arrowheads
indicate slow fibers showing the high-
est Csl fluorescence. Bars indicate
length in micrometers. at, atrium; bl,
bladder; dm, diaphragm; gs, gastrocne-
mius; ic, intercostal muscle; li, liver; pl,
plantaris; si, small intestine; so, soleus;
st, stomach; ve, ventricle. Bars: (A, B,
and D) 500  m; (C) 1  m; (E–G) 200
 m; (H and I) 100  m.Palmer et al. Expression and Role of Muscle-specific Protein Csl 991
flanking the Z-line, the point of attachment of actin thin
filaments of adjacent sarcomeres seen as a single line of
 -actinin in double immunofluorescence (Fig. 6, D–F). This
pattern suggests localization to costameres, subsarcolem-
mal sites of cytoskeletal/membrane adhesion complexes
(Pardo et al., 1983; Berthier and Blaineau, 1997). Indeed,
Csl colocalized with talin (Fig. 6, G–I), a large protein with
actin-, vinculin-, integrin-, and dystrophin-binding activi-
ties enriched in a variety of matrix–cytoskeleton adhesive
complexes, including costameres (Berthier and Blaineau,
1997). A weak single stripe of Csl expression was also seen
between the strong doublets at the level of the M-line (Fig.
6 C). Unlike  -actinin, which is located throughout the
myofibril at the level of the Z-line (Fig. 6 L), Csl was
present predominantly surrounding or between myofibrils
(Fig. 6 K). The honeycomb-like pattern of Csl in trans-
verse sections of fetal myotubes resembled that of the in-
termediate filament protein desmin, which precisely sur-
Figure 6. Subcellular localization of
Csl protein. (A and B) Double immuno-
fluorescence on a section of E18.5 skel-
etal muscle showing localization of Csl
(A) and  -actinin (B). (C) High power
double immunofluorescence confocal
image (overlay) of a section of stretched
adult soleus (see D–F) showing Csl
(green) and  -actinin (red). Arrow-
heads indicate weak Csl staining over
the M-line. (D–F) Double immunofluo-
rescence confocal image of a section of
stretched adult soleus showing Csl (D),
 -actinin (E), and overlay (F). (G–I)
Confocal images of Csl (G) and talin
(H) with overlay (I). (J) Overlay of Csl
and talin double immunofluorescence in
myotendenous junctions (arrowheads).
(K and L) Transverse sections of E17.5
myotubes showing Csl (K) and  -acti-
nin (L). (M–O) Double immunofluo-
rescence of Csl (M) and  -actinin (N)
with overlay (O) in adult ventricular
myocytes. Arrowheads indicate Csl
staining over the M-line. mf, myofiber;
tn, tendon. Bars: (A, B, D–I, and K–L)
20  m; (C) 10  m; (J) 50  m.The Journal of Cell Biology, Volume 153, 2001 992
rounds the Z-line of myofibrils in a cage-like manner in
continuity with costameres at the membrane (Granger and
Lazarides, 1979). Csl also colocalized with talin in myoten-
donous junctions (Fig. 6 J).
The Csl pattern in adult cardiac muscles appeared iden-
tical to that found in the soleus (Fig. 6, M–O), although the
smaller size of the cardiac cells made individual bands
more difficult to resolve. Nevertheless, doublets flanking
the Z-line and an association with the M-line were evident.
The M-line signal was more prominent than in skeletal
muscles (Fig. 6 C).
Dominant Effects of Csl in C2C12 Cells
We overexpressed Csl in the C2C12 myogenic cell line
(Blau et al., 1983) and examined effects on myoblasts and
myocyte formation in the presence and absence of insulin-
like growth factor (IGF)-1, a known proliferative, viabil-
ity, promyogenic, hypertrophic, and repair factor for mus-
cle cells (Coolican et al., 1997; Gredinger et al., 1998;
Goldspink, 1999; Musaro and Rosenthal, 1999; Musaro et
al., 1999; Semsarian et al., 1999; Lawlor and Rotwein,
2000). Prior studies in the rat L6E9 line demonstrated that
enforced Csl expression induced formation of large hyper-
trophied myotubes after 2 d of differentiation in the pres-
ence of IGF-1 (Musaro, A., and N. Rosenthal, personal
communication). In this study, C2C12 lines stably express-
ing FLAG-Csl under control of the EF1  promoter were
analyzed in detail.
Dominant effects of ectopic FLAG-Csl were first seen at
the myoblast stage. In the FC18 Csl-expressing line, myo-
blasts appeared larger than the F5 vector–only control line
due to induction of prominent lamellipodia accompanied
by membrane ruffling. To ensure that this was not due to
clonal variation or the nature of the epitope tag, we gener-
ated further stable lines expressing myc epitope–tagged Csl
under control of the EF1  promoter and the myosin light
chain-1F promoter/3  enhancer (MLC1), the latter ex-
pressed in myocytes but not in myoblasts (Musaro and
Rosenthal, 1999). An additional control line expressed
green fluorescent protein (GFP) under cytomegalovirus
promoter control. These new lines were established in a
different clonal isolate of C2C12 that underwent more
rapid differentiation in low serum (see Materials and
Methods). EF1 -myc-Csl lines but not parental or control
lines showed prominent lamellipodia (Fig. 7, A and B). To
quantify the effects, we measured mean cell area using
planimetry. Myc-Csl– and FLAG-Csl–expressing myo-
blasts showed a significant increase in area (Fig. 7 C), most
pronounced in the myc-Csl lines ME1 and ME2. The myc-
Csl lines MM1 and MM2, which do not express Csl in myo-
blasts, were the same size as those carrying GFP vector–
only or untransfected controls. This effect was due solely to
cell spreading on the tissue culture dish, since flow cytome-
try using forward light scatter showed that the volume of
detached Csl-myoblasts was no different from that of con-
trols (Fig. 7, D and E). Immunofluorescence of myc-Csl–
expressing myoblasts revealed that a proportion of Csl pro-
tein became localized to membrane ruffles at the leading
edge of lamellipodia (Fig. 7 G) and to focal adhesions (not
shown). Membrane ruffle localization of a fusion protein
consisting of GFP linked in frame to the NH2 terminus of
Csl was also evident after expression in myoblasts (Fig. 7
Figure 7. Effect of constitutive Csl expression in C2C12 myo-
blasts. (A and B) Phase–contrast images of stable C2C12 clones
constitutively expressing GFP (A) or myc-Csl (B). (C) Mean myo-
blast area (   SEM) of parental C2C12 cells and a series of
transfected myc- or FLAG-Csl–expressing clones. GV is trans-
fected with GFP vector only; ME1/2 are lines expressing myc-Csl
driven by EF1  promoter; MM1/2 are lines expressing myc-Csl
driven by differentiation-dependent MLC1 promoter/enhancer.
Only ME1, ME2, and FC18 express Csl in myoblasts. (D) Over-
lay of forward light scatter histograms from a single experiment
in which C2C12 stable clones (GV, ME1, ME2, MM1, MM2) and
parental cell line were compared. As positive control, GV cells
were resuspended in hypotonic 0.5  PBS causing a rightward
shift. (E) Mean forward light scatter (  SEM) determined from
three separate experiments and plotted as a percentage of con-
trols. (F) Mean percentage (   SEM) of closure of 150- m
wounds in confluent monolayers after 6 h. (G) Anti-myc anti-
body immunofluorescence in a myc-Csl–expressing myoblast.
(H) GFP fluorescence in a C2C12 myoblast transiently express-
ing GFP–Csl fusion protein. Bars, 20  m.Palmer et al. Expression and Role of Muscle-specific Protein Csl 993
H). Despite their prominent lamellipodia, Csl-expressing
myoblasts migrated more slowly than controls in a cell
monolayer wound repair migration assay (Fig. 7 F).
Csl Induces Myosacs in C2C12 Cells
in an IGF-1–dependent Fashion
After transfer to low serum medium, FLAG-Csl cells were
delayed in the onset of myotube formation by 12–24 h,
seen also as a delay in the onset of expression of the
bHLH factor myogenin and the cyclin/cdk inhibitor
p21WAF1/Cip1 (data not shown). Nevertheless, differentia-
tion into long thin myotubes occurred relatively normally
(Fig. 8, A and B). We therefore assessed the outcome of
adding recombinant human IGF-1 to differentiating cul-
tures. The effects of IGF-1 on muscle cells are dose depen-
dent, and at the high concentration used in these experi-
ments (100 ng/ml; 13 nM) proliferation is the favored
response (Coolican et al., 1997; Layne and Farmer, 1999).
Thus, IGF-1 added to control cultures from the beginning
of differentiation induced an extended period of myoblast
proliferation and a higher density of cells in differentiating
cultures but no obvious hypertrophy (Fig. 8 C). However,
addition of IGF-1 to FLAG-Csl cells induced formation of
massively hypertrophied myotubes throughout the culture
after 3 d of differentiation (Fig. 8 D). These cells, dubbed
“myosacs” (Yotov and St-Arnaud, 1996), were highly
branched and contained many nuclei. They resembled myo-
tubes induced in L6E9 and related muscle cell lines by
IGF-1 (Coolican et al., 1997; Musaro et al., 1999) and in C2
cells by a variety of stimuli, including treatments that
enhance cell fusion (Yagami-Hiromasa et al., 1995; Hi-
rayama et al., 1999). All three FLAG-Csl lines examined
exhibited the same phenotype, although myosacs were not
observed in any of the myc-Csl lines (see Discussion). Al-
though myosacs were highly dysmorphogenic, immuno-
staining revealed no obvious mislocalization of myosin
heavy chains, actin, tubulin, or  -actinin (Fig. 8, G and H;
data not shown).
Csl Augments the Activity of NFAT and MEF2 
Transcription Factors in the Presence of IGF-1
To determine whether myosac formation reflected in-
creased myogenesis, we assayed the expression of several
muscle genes in FC18 and F5 cultures using Northern blot-
ting (Fig. 9 A). No significant effects on mRNAs for myo-
genin, MEF2C, and embryonic myosin heavy chain were
discernible either in the presence or absence of IGF-1.
Analysis of protein to DNA ratios in differentiating cul-
tures (Fig. 9 B) showed that the myosac phenotype was
not the result of increased anabolic metabolism (increased
protein synthesis relative to DNA synthesis), a component
of skeletal muscle hypertrophy (Goldspink, 1999). Indeed,
Csl actually decreased protein to DNA ratios at late times
in the culture, independently of IGF-1. We also measured
the activities of transfected reporter genes dependent on
the transcription factors NFAT and MEF2, both of which
are known to be important for skeletal muscle differentia-
tion and hypertrophy (Abbott et al., 1998; Wu et al., 2000).
In control cultures, the activities of NFAT (assayed on a
2-kb myoglobin promoter relative to a mutant version lack-
ing NFAT sites [Chin et al., 1998]) and MEF2 (assayed on
three MEF2-binding sites juxtaposed to a minimal pro-
moter relative to minimal promoter only [Chen et al.,
2000]) were low at early stages of differentiation but in-
creased progressively to day 4 (Fig. 10, A–D). Although
IGF-1 elevated levels of MEF2 and to a lesser extent
NFAT (Fig. 10, B and D), FLAG-Csl in the presence of
IGF-1 induced a significant further increase in both NFAT
and MEF2 activity after 3 d (Fig. 10, B and D). The NFAT
effect was seen in all three FLAG-Csl lines analyzed.
NFAT and MEF2 are targets of the Ca2 /calcineurin sig-
naling pathway (Abbott et al., 1998; Chin et al., 1998;
Molkentin et al., 1998; Semsarian et al., 1999; Delling et
al., 2000; Wu et al., 2000). However, we found that the Csl/
IGF-1–mediated increase in NFAT activity was largely re-
sistant to the calcineurin inhibitory drug CsA (1  M) (Fig.
10 F). CsA at this dose effectively blocked calcineurin ac-
tivity, since it completely inhibited the increase in NFAT
activity conferred by transient expression of a constitu-
tively active calcineurin variant at day 4 (Chin et al., 1998)
Figure 8. Effects of constitutive FLAG-Csl expression in differen-
tiating C2C12 myogenic cells. Phase–contrast and immunofluores-
cence images of control (F5; left panels) and FLAG-Csl–expressing
(FC18; right panels) C2C12 cells after 3 d of differentiation. (A and
B) No treatment. (C and D) With 100 ng/ml IGF-1. (E and F) With
100 ng/ml IGF-1 plus 1  M CsA. (G and H) MF20 immunofluores-
cence on cells treated with IGF-1. Bars, 100  m.The Journal of Cell Biology, Volume 153, 2001 994
(Fig. 10 F). In the C2C12 subline used in these experi-
ments (see Materials and Methods), calcineurin activity
assayed in extracts was low at early stages of the culture
but increased with further differentiation (Fig. 10 E). Ac-
tivity was stimulated by the presence of IGF-1 as demon-
strated previously (Semsarian et al., 1999), although there
was no further increase with FLAG-Csl (Fig. 10 E). In
contrast to primary muscle cultures and other cell lines
(Musaro et al., 1999; Delling et al., 2000; Friday et al.,
2000), differentiation in this line appeared totally resistant
to CsA added either at the beginning of differentiation or
up to 3 h beforehand (Fig. 8 E). This fact has allowed us to
uniquely assess whether myosac formation was resistant to
CsA, uncomplicated by effects of the drug on differentia-
tion. However, myosac formation was totally insensitive to
CsA (Fig. 8, E and F).
Discussion
We have cloned a cDNA encoding the 9-kD muscle-spe-
cific protein Csl in a screen for novel transcriptional targets
of the cardiac homeodomain factor Nkx2-5 (Harvey,
1996). In embryonic hearts, Csl was expressed exclusively
at the outer curvature of the ventricles and in the atrial ap-
pendages but not at the inner curvature. The Csl-positive
domains appear to define regions that will form the work-
ing myocardium of the heart chambers, which are specified
at the outer curvature in response to anterior/posterior and
dorsal/ventral patterning information (Christoffels et al.,
2000). Indeed, Csl is one of few markers that highlight the
primordia of chamber myocardium in very early hearts.
The pattern of Csl expression in the sinoatrial region of
the heart is also noteworthy in light of its complex devel-
opment and lineage contributions (Anderson et al., 1999).
Csl transcripts were seen in the developing right atrial ap-
Figure 9. Myogenic gene expression and protein to DNA ratios
in control (F5) and FLAG-Csl (FC18) C2C12 cells in the pres-
ence and absence of IGF-1 (100 ng/ml). (A) Northern blot analy-
sis of total RNA from cells cultured for 0–5 d in differentiation
medium using indicated probes. Ethidium bromide (EtBr) stain-
ing of 28S and 18S ribosomal RNAs serves as loading control.
Two mRNA species are produced from the transgene due to dif-
ferential 3  untranlated region processing. (B) Total protein/total
DNA ratios   SEM at different times of differentiation. Myog,
myogenin; Mhc, embryonic myosin heavy chain.
Figure 10. NFAT, MEF2, and calcineurin activity in control
(F5) and FLAG-Csl (FC18) cells with and without IGF-1 (100 ng/
ml). (A and B) Mean NFAT-dependent transcriptional activity
(  SEM) measured using a transfected luciferase reporter gene
driven by the myoglobin promoter (Mygb), compared with the same
promoter with mutated NFAT-binding sites (Mygb  -NFAT). (C
and D) Mean MEF2-dependent transcriptional activity (  SEM)
measured using a transfected luciferase reporter containing three
MEF2-binding sites (3 MEF) compared with the minimal vector
(Vector only). (E) Levels of calcineurin phosphatase activity
measured in vitro as picomoles of 32P-radiolabeled phosphate re-
leased per minute per microgram of extract (pmol/min/ g). (F)
Effect of CsA (1  M) on NFAT activity measured using the wild-
type myoglobin (Mygb) reporter at day 4 in FC18 cells after treat-
ment with IGF-1 (left) or after transient transfection of activated
calcineurin A subunit (Act-CnA) (right).Palmer et al. Expression and Role of Muscle-specific Protein Csl 995
pendage and right sinus horn, the latter becoming incorpo-
rated into the right atrium as development proceeds
(Anderson et al., 1999). However, the left sinus horn did
not express detectable levels of Csl at early times. This
horn is not substantially incorporated into the atrium, but
retains its original walls to form in humans the coronary si-
nus and in the mouse the persistent connection to the left
superior vena cava. The above findings suggest that myo-
cytes forming the working component of heart chambers
undergo transition to a more specialized myogenic pheno-
type via a distinct Nkx2-5–dependent genetic program.
Using a polyclonal antibody, we detected Csl protein in
the heart, all skeletal muscles, and smooth muscles of the
stomach and lungs, and this distribution was confirmed by
staining for hPAP in Csl knockout mice. The intracellular
localization of Csl protein was complex. In embryonic and
fetal cardiac and skeletal muscles and in C2C12 myotubes,
Csl was present throughout the cytoplasm of the cell, even
in the presence of well-formed myofilamentous structures.
However, Csl became associated with the sarcomeric cyto-
skeleton as myofibers matured. This was predominantly in
a costameric pattern. Costameres are discrete, rectilinear,
subsarcolemmal domains that appear as transverse stripes
along the muscle fiber (Pardo et al., 1983; Berthier and
Blaineau, 1997) originally defined by the expression pat-
tern of vinculin, which aligns with I-band regions of the
sarcomere flanking the Z-lines. Costameres contain su-
pramolecular complexes of focal adhesion–type, spectrin-
based, and dystrophin-based cytoskeletal membrane adhe-
sion systems that are thought to stabilize the sarcolemma
of muscle cells by distributing force to the extracellular
matrix during contractions (Berthier and Blaineau, 1997).
Many of the proteins that localize to or are enriched in
costameres are also found in myotendonous and neuro-
muscular junctions in muscle cells and in focal adhesions
and membrane ruffles in nonmuscle cells (Berthier and
Blaineau, 1997; Brancaccio et al., 1999). In addition to
their mechanical functions, the above structures tether
many signaling molecules, which control mechanorecep-
tion, cytoskeletal remodelling, and other myogenic func-
tions in response to internal and external stimuli (Berthier
and Blaineau, 1997; Goldspink, 1999). The pattern of Csl
immunofluorescence in skeletal muscle cells suggests that
Csl is localized both within subsarcolemmal costameres
and intracellularly in paired rings flanking the Z-lines of
myofibrils seen typically as a honeycomb pattern in trans-
verse sections. A lower level of Csl protein was also seen
between the I-band doublets overlying the M-line, showing
that Csl is not localized exclusively to the costameric lat-
tice. Levels of Csl protein also showed a distinct fiber-type
bias in skeletal muscle cells, suggesting modulation by neu-
ronal input and/or load (Goldspink, 1999). In cardiocytes,
the Csl pattern appeared essentially identical to that in
slow skeletal muscle. These complex distributions hint at
functions (perhaps multiple) in cytoskeletal/myofilament
organization and regulation and/or associated signaling.
We have approached the function of Csl by gene knock-
out and overexpression experiments. The conditional
knockout allele of Csl, which appears to be null, showed
no overt developmental phenotype in skeletal muscle or
heart, suggesting genetic or functional redundancy and/or
a dedicated role in muscle adaptation and regeneration.
Analysis of responses to stress, injury, and aging in mus-
cles of knockout mice is underway. Overexpression of Csl
in C2C12 myogenic cells induced several dominant effects.
In myoblasts, ectopic Csl induced lamellipodia, and Csl
protein became localized to leading edge membrane ruf-
fles and focal adhesions. It is well established that cell divi-
sion and changes in cell shape and behavior, including for-
mation of lamellipodia and membrane ruffling during cell
migration, are mediated by actomyosin cytoskeletal dy-
namics and require the Rho family of small GTPases
(Kaibuchi et al., 1999; Bishop and Hall, 2000). Formation
of lamellipodia seems to be mediated predominantly by
Rac1 and stress fibers, and focal adhesion by Rho (Nobes
and Hall, 1995). These findings suggest that ectopically ex-
pressed Csl may engage up- or downstream elements of
Rho/Rac-signaling cascades and thus dysregulate actomy-
osin dynamics. Paradoxically, Csl-expressing cells could
not efficiently migrate into cell monolayer wounds. In ad-
dition to inducing lamellipodia, Csl may stabilize trailing
edge focal adhesions, which normally must disassemble
during migration. Whether the effects relate to the normal
role of Csl must remain highly speculative at this point,
since Csl is not normally expressed in myoblasts. How-
ever, there is an intriguing connection between the domi-
nant functions of Csl in myoblasts and its localization to
costameres in normal muscle cells, which share many fea-
tures of other actin membrane adhesion systems such as
lamellipodia (Berthier and Blaineau, 1997).
During differentiation of C2C12 cells in low serum, Csl
overexpression induced formation of large dysmorpho-
genic myosacs in an IGF-1 signaling–dependent manner.
This phenotype did not appear to be due to augmented
myogenesis nor was it accompanied by an increase in
anabolic metabolism, a component of skeletal muscle
hypertrophy. Furthermore, myosac formation was CsA in-
sensitive and therefore independent of the Ca2 /calmodulin–
dependent phosphatase calcineurin (Rusnak and Mertz,
2000) implicated in skeletal muscle hypertrophy in vitro
and in vivo (Dunn et al., 1999; Musaro et al., 1999; Semsar-
ian et al., 1999). Since Csl-induced myosacs contained
large numbers of nuclei, we favor the hypothesis that in
the C2C12 line, myosacs form through augmentation and
dysregulation of myocyte fusion. Myocyte fusion occurs in
a complex and highly orchestrated progression involving
cell recognition, adhesion, alignment, and membrane fu-
sion (Doberstein et al., 1997; Hirayama et al., 1999). Im-
portantly, induction of promiscuous fusion in C2 cells with
Sendai virus or metalloprotease disintegrin overexpres-
sion induces a myosac-like phenotype (Yagami-Hiromasa
et al., 1995; Hirayama et al., 1999), and expression of dom-
inant negative forms of Rac1 in Drosophila muscle precur-
sors induces promiscuous fusion and formation of myosac-
like muscles in situ (Luo et al., 1994). Thus, it is possible
that the two dominant effects of overexpressed Csl dis-
cussed above share a common mechanism, that is, pertur-
bation of regulated cytoskeletal dynamics. However, Myc-
Csl overexpression did not induce myosacs in a subline of
C2C12 cells that differentiate 1–2 d in advance of those in
which myosacs were observed. Although the reason for
this is unclear, it is possible that the rat L6E9 line in which
the myosac phenotype was initially observed and the per-
missive C2C12 line have become less robust with respectThe Journal of Cell Biology, Volume 153, 2001 996
to regulation of cytoskeletal remodelling due to adapta-
tions to tissue culture.
In addition to its dominant effects on myoblast and myo-
cyte cell shape and behavior, Csl also augmented the ac-
tivities of the NFAT and MEF2 families of transcription
factors in an IGF-1 signaling–dependent manner at late
stages in the culture. For NFAT, this effect was largely
CsA insensitive, indicating that it did not involve the cal-
cineurin pathway. The mechanism of this augmentation is
unknown, although it highlights the fact that overexpres-
sion of Csl can influence intracellular signaling events in
addition to structural changes. Since both NFAT and
MEF2 regulate the myoglobin promoter, which is selec-
tively expressed in slow fibers (Chin et al., 1998), and since
Csl itself is enriched in slow fibers, overexpression of Csl
in C2C12 cells may promote a slow fiber phenotype. It is
also possible that the activity of NFAT and MEF2 like that
of serum response factor, a key transcriptional regulator in
muscle cells, is stimulated by increased actin dynamics
(Sotiropoulos et al., 1999). Although we acknowledge that
overexpression experiments require cautious interpreta-
tion, further analysis of the above effects may offer new in-
sights into Csl function in muscle cells and the prominent
role played by the cytoskeleton and myofilament and its
associated signaling molecules in muscle development,
function, and disease.
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